Who we are

Our Mission
Keystone Biologics Advisory provides independent, principal-led CMC guidance for emerging and late-stage programs. We specialize in complex biologics—including cell and gene therapies—helping biotech innovators build readiness for US FDA pre-IND meetings, IND, and BLA submissions.

Strategic Partnership
We work directly with founders and scientists to provide strategic oversight, ensuring CMC programs are practical, structured, and phase-appropriate. In an evolving regulatory landscape, our deep expertise ensures your manufacturing and quality strategies are optimized for success under the latest 2026 FDA flexible framework.

The Keystone Approach
We collaborate seamlessly with sponsors, external experts, and partner organizations, offering high-level guidance without the overhead of in-house teams or operational staff. Our approach is discreet, precise, and experience-driven—designed to bridge the gap between breakthrough science and regulatory approval.